Speakers

Organised by

Integrating the pharma supply chain7-8 June | Brussels, Belgium

IRA SMITH

Director Strategic Development Global Transport and Logistics

Pelican BioThermal

ALAN KENNEDY

DirectorPartnerSave Ltd

JEAN VERHEYEN

Chief Executive Officer Nallian

NATHAN DE VALK

Cargo Account ManagerBrussels Airport

Company

ANDREW LESTER

Global Director,Healthcare Vertical Expeditors

LUDOVIC MÉNÉDÈME

Head of Global Distribution, Customer Service and Commercial Relationships UCB Biopharma

STAVROS EVANGELAKAKIS

Global Product Manager Cargolux Airlines

DIA ROMANOWICZ

Head of Global Sales – Thermal Products, Commercial Cargo

AmSafe Bridport

HENRY MORAN

Director ASC Associates

MALIK ZENITI

Manager Cluster for Logistics,

Luxembourg

AN D’HONDT

Head of Business Line HealthcareKatoen Natie

THERESE PUETZ

Chief Executive Officer Karavan Management

Consulting

HUGH WILLIAMS

Managing DirectorHughenden Consulting

MANU JACOBS

Director of Global Business Development Air France-KLM Cargo

MARK BLANCHARD

Facilitator, BioPhorum

Operations Group

& Director, Orca

Partnership

CHAIR

Brussels | Belgium

7-8 June | Brussels, Belgium

PROGRAMME 2016 Host Sponsor Gold Sponsor Silver Sponsor

Association Patrons

Speakers

Join us next year at FlyPharma in June 2017! www.fl ypharmaconference.com

FRANK BECKX

Managing Directoressenscia vlaanderen

GERARD DE WIT

Managing DirectorWorldACD Market Data

GINO VLEUGELS

Senior ManagerEMEA Temperature Control Johnson & Johnson

EDWIN VISSER

Senior Director of Sales EMEA CSafe Global

EDDY WEYGAERTS

Senior Manager, Logistics Delivery ELC & ES EUPfizer

DIRK DEMAESSCHALCK

Senior TransportationAnalystPfizer

MARK EDWARDS

Managing Director Modalis

Conference Agenda | Day 1 7 June 2016 Conference Agenda | Day 2 8 June 201608.00 REGISTRATION & COFFEE

08.45 INTRODUCTORY ADDRESS Chair Mark Blanchard opens the conference.

09.00 OPENING KEYNOTE: BELGIUM IS WORLD-CLASS FOR BIOPHARMACEUTICAL R&D, MANUFACTURING AND LOGISTICS How did such a small country as Belgium become a key player in the European pharmaceutical industry? And why is it that all top 10 global pharmaceutical companies develop key activities there, ranging from R&D centres and production facilities to clinical trials and logistics? Frank Beckx, Managing Director of essenscia vlaanderen, the Federation for Chemistry and Life Sciences Industries, will zoom into the five main reasons why Belgian biopharma is delivering medical breakthroughs for worldwide diseases, and how the industry and supportive government policies are building a stronger future for Belgium as the pharmaceutical laboratory for patients around the globe.

09.45 DEALING WITH COMPLIANCE AND COMPLEXITY: HOW ARE PHARMA COMPANIES MANAGING THEIR AIR SHIPMENTS? We are all affected by the same supply chain challenges, but maintaining a patient-focused mindset will give you a snapshot of the main learnings and initiatives to maintain each shipment’s integrity. Logistical partners at the airport – forwarding agents, handling agents and airlines – must offer efficient and dedicated pharma procedures, allowing an integrated cold chain. Ludovic Ménédème at UCB Biopharma shows how stronger collaboration between shippers could help to design, deliver and complete efficient solutions.

10.30 ETHIOPIAN AIRLINES CARGO OVERVIEW A short presentation from our sponsor, Ethiopian Airlines. 10.35 COFFEE & NETWORKING

11.00 TOWARDS AN INTEGRATED APPROACH TO GDP COMPLIANCE Andrew Lester from Expeditors reveals how an integrated approach is needed to address the issues surrounding different GDP regulations, including their varying interpretation and standard of enforcement in a global context. 11.45 DATA-DRIVEN LOGISTICS Are you information-driven or is information driving you mad? Jean Verheyen at Nallian advises how to keep your head above water in an ocean of Big Data.

12.30 ANNOUNCING AN INNOVATIVE NEW THERMAL COVER A short presentation from our sponsor, DuPont.

12.35 LUNCH

14.00 INSPIRED BY CLINICAL SUPPLY IN AFRICA Gino Vleugels from Johnson & Johnson presents a case study about the supply chain for the Ebola vaccine into Sierra Leone and how the local culture could make the difference.

15.00 MODAL SHIFT (PANEL DEBATE) As rates plummet, pharma shippers are increasingly becoming attracted to inter-continental rail freight services as well

as sea freight. Where are these trends going to lead? Panellists: Eddy Weygaerts, Pfizer • Gerard de Wit, WorldACD Market Data • Manu Jacobs, Air France-KLM Cargo • Ira Smith, Pelican BioThermal • Mark Edwards, Modalis. Moderator: Malik Zeniti, Cluster for Logistics, Luxembourg

15.45 COFFEE & NETWORKING

16.00 MULTIMODAL PHARMA CONSOLIDATION: DREAM OR REALITY? Bringing common sense into the organisation of the pharma shipper’s supply chain: Katoen Natie’s An D’Hondt highlights how to offer consolidation and collaboration for ocean and air freight in a multimodal way.

16.45 SUPPLY CHAIN SECURITY What does the logistics sector need to do to comply with the Falsified Medicines Directive? Henry Moran at ASC Associates describes how to better control supply chain security risks.

17.30 END OF DAY 1 SESSIONS

18.30 NETWORKING RECEPTION & DINNER Join us at the end of Day 1 for drinks, a three-course dinner and an opportunity to network with speakers and delegates. Drinks start at 18.30, dinner from 19.00.

08.00 COFFEE & NETWORKING

08.45 OPENING REMARKS Summary of Day 1 and an overview of Day 2 from Chair Mark Blanchard.

08.55 FLYING BIO How the global BioPhorum Operations Group is shaking up biotech innovation, knowledge transfer and operational best practice through a collaborative approach. Presented by Mark Blanchard.

09.15 HOW DO WE COLLABORATE? WHERE DO WE START? When you look up “collaboration” in the dictionary, there are two definitions: the action of working with someone to produce something; and traitorous cooperation with an enemy. These definitions illustrate the emotions we must deal with when we try to collaborate. On the one hand, there is the logical belief that working together must achieve something, but at the same time, we don’t want to give too much away to our “enemy”. True collaboration is the skill of overcoming our natural customer/supplier instincts to ensure the relationship is truly win-win. So, where do we start? Hugh Williams at Hughenden Consulting shares his advice.

10.00 TAKING THE MEDICINE Therese Puetz at Karavan Management Consulting looks at innovation, investment and new ways of working that are transforming pharma air logistics.

10.45 COFFEE & NETWORKING

11.15 ROUTE QUALIFICATION: PRACTICAL STEPS TOWARDS COMPLIANCE Good Distribution Practice guidelines allow for route qualification, but what is this? Mark Edwards at Modalis has recently been working with a major pharmaceutical manufacturer to understand and apply this throughout their global logistics operation. In his presentation, Mark will reveal what steps you need to take in order to qualify your routes and achieve GDP compliance in a cost-effective manner, irrespective of transport mode.

12.00 COLLABORATION: A QUESTION OF TRUST (PANEL DEBATE) Years to build, seconds to break, forever to repair. At the end of the day, real collaboration comes down to trust. Do the panel members think that sufficient trust can be generated amongst pharma and logistics providers for real integration to become the norm? Panellists: Dirk De Maesschalck, Pfizer • Dia Romanowicz, AmSafe Bridport • Stavros Evangelakakis, Cargolux • Nathan De Valck, Brussels Airport. Moderator: Alan Kennedy, PartnerSave 12.45 LUNCH

14.00 LEAN AND GREEN SOLUTIONS The Paris Agreement promises big changes and air freight is a prime target for CO

2 reductions. What does this mean

for airlines and who will take the lead? Malik Zeniti from Cluster for Logistics, Luxembourg explores this pressing issue in his presentation.

14.45 LIFECYCLE LOGISTICS As pharma logistics becomes more complex and as human safety considerations tighten, there is a growing need for shippers to balance capital costs with support, maintenance and readiness costs. Such Integrated Logistics Support or Total Cost of Ownership strategies are designed to optimise the lifecycle cost:performance ratio of cold chain systems. Find out more from Edwin Visser at CSafe.

15.30 CLOSING KEYNOTE Presented by Hugh Williams at Hughenden Consulting.

16.00 CLOSE OF EVENT

Refreshments and further networking available

www.fl ypharmaconference.com www.fl ypharmaconference.com

Read more from our speakers and discover bonus content at

www.flypharmaconference.com/event-and-speaker-blogs

Presentations available exclusively to delegates post-event

7-8 June | Brussels, Belgium 7-8 June | Brussels, Belgium